Literature DB >> 7686186

Neutralizing antibodies in cats infected with feline immunodeficiency virus.

F Tozzini1, D Matteucci, P Bandecchi, F Baldinotti, K Siebelink, A Osterhaus, M Bendinelli.   

Abstract

Sera from cats experimentally infected with five isolates of feline immunodeficiency virus (FIV) from various geographical regions and from FIV enzyme-linked immunosorbent assay-seropositive field cats from four European countries neutralized the Petaluma strain of FIV (FIV-P), originally isolated in California, at high titers. In addition, FIV-P and a European isolate proved equally susceptible to neutralization by all sera tested. Coupled with observations by Fevereiro et al. (M. Fevereiro, C. Roneker, A. Laufs, L. Tavares, and F. de Noronha, J. Gen. Virol. 72:617-622, 1991), these findings indicate that most if not all FIV strains circulating in Europe and the United States share important neutralization-inducing epitopes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7686186      PMCID: PMC265592          DOI: 10.1128/jcm.31.6.1626-1629.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  21 in total

1.  Comparison of two host cell range variants of feline immunodeficiency virus.

Authors:  T R Phillips; R L Talbott; C Lamont; S Muir; K Lovelace; J H Elder
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

2.  Development and evaluation of immunoassay for detection of antibodies to the feline T-lymphotropic lentivirus (feline immunodeficiency virus).

Authors:  T P O'Connor; S Tanguay; R Steinman; R Smith; M C Barr; J K Yamamoto; N C Pedersen; P R Andersen; Q J Tonelli
Journal:  J Clin Microbiol       Date:  1989-03       Impact factor: 5.948

3.  Clinical and laboratory findings in cats infected with feline immunodeficiency virus.

Authors:  C D Hopper; A H Sparkes; T J Gruffydd-Jones; S M Crispin; P Muir; D A Harbour; C R Stokes
Journal:  Vet Rec       Date:  1989-09-23       Impact factor: 2.695

4.  Isolation of a T-lymphotropic lentivirus from a persistently leucopenic domestic cat.

Authors:  D A Harbour; P D Williams; T J Gruffydd-Jones; J Burbridge; G R Pearson
Journal:  Vet Rec       Date:  1988-01-23       Impact factor: 2.695

5.  An enzyme linked immunosorbent assay (ELISA) for the detection of feline immunodeficiency virus (FIV) antigen in cell culture and FIV specific antibodies in feline serum.

Authors:  C H Siebelink; R W Windrich; I Chu; J Groen; K Weijer; F G UytdeHaag; A D Osterhaus
Journal:  Dev Biol Stand       Date:  1990

6.  Epidemiologic and clinical aspects of feline immunodeficiency virus infection in cats from the continental United States and Canada and possible mode of transmission.

Authors:  J K Yamamoto; H Hansen; E W Ho; T Y Morishita; T Okuda; T R Sawa; R M Nakamura; N C Pedersen
Journal:  J Am Vet Med Assoc       Date:  1989-01-15       Impact factor: 1.936

7.  Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats.

Authors:  J K Yamamoto; E Sparger; E W Ho; P R Andersen; T P O'Connor; C P Mandell; L Lowenstine; R Munn; N C Pedersen
Journal:  Am J Vet Res       Date:  1988-08       Impact factor: 1.156

8.  Second conserved domain of gp120 is important for HIV infectivity and antibody neutralization.

Authors:  D D Ho; J C Kaplan; I E Rackauskas; M E Gurney
Journal:  Science       Date:  1988-02-26       Impact factor: 47.728

9.  Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome.

Authors:  N C Pedersen; E W Ho; M L Brown; J K Yamamoto
Journal:  Science       Date:  1987-02-13       Impact factor: 47.728

10.  Human immunodeficiency virus 1. Predominance of a group-specific neutralizing epitope that persists despite genetic variation.

Authors:  I Berkower; G E Smith; C Giri; D Murphy
Journal:  J Exp Med       Date:  1989-11-01       Impact factor: 14.307

View more
  12 in total

1.  Studies of AIDS vaccination using an ex vivo feline immunodeficiency virus model: protection conferred by a fixed-cell vaccine against cell-free and cell-associated challenge differs in duration and is not easily boosted.

Authors:  D Matteucci; M Pistello; P Mazzetti; S Giannecchini; D Del Mauro; I Lonetti; L Zaccaro; C Pollera; S Specter; M Bendinelli
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

2.  Sequential CD134-CXCR4 interactions in feline immunodeficiency virus (FIV): soluble CD134 activates FIV Env for CXCR4-dependent entry and reveals a cryptic neutralization epitope.

Authors:  Aymeric de Parseval; Chris K Grant; K Jagannadha Sastry; John H Elder
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

3.  Neutralization of feline immunodeficiency virus by polyclonal feline antibody: simultaneous involvement of hypervariable regions 4 and 5 of the surface glycoprotein.

Authors:  K H Siebelink; W Huisman; J A Karlas; G F Rimmelzwaan; M L Bosch; A D Osterhaus
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

4.  Vaccination protects against in vivo-grown feline immunodeficiency virus even in the absence of detectable neutralizing antibodies.

Authors:  D Matteucci; M Pistello; P Mazzetti; S Giannecchini; D Del Mauro; L Zaccaro; P Bandecchi; F Tozzini; M Bendinelli
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

5.  A neutralizing antibody-inducing peptide of the V3 domain of feline immunodeficiency virus envelope glycoprotein does not induce protective immunity.

Authors:  S Lombardi; C Garzelli; M Pistello; C Massi; D Matteucci; F Baldinotti; G Cammarota; L da Prato; P Bandecchi; F Tozzini
Journal:  J Virol       Date:  1994-12       Impact factor: 5.103

Review 6.  Feline immunodeficiency virus: an interesting model for AIDS studies and an important cat pathogen.

Authors:  M Bendinelli; M Pistello; S Lombardi; A Poli; C Garzelli; D Matteucci; L Ceccherini-Nelli; G Malvaldi; F Tozzini
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

Review 7.  Lentivirus-induced immune dysregulation.

Authors:  Mary B Tompkins; Wayne A Tompkins
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

8.  Serum neutralization of feline immunodeficiency virus is markedly dependent on passage history of the virus and host system.

Authors:  F Baldinotti; D Matteucci; P Mazzetti; C Giannelli; P Bandecchi; F Tozzini; M Bendinelli
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

9.  Kinetics of replication of a partially attenuated virus and of the challenge virus during a three-year intersubtype feline immunodeficiency virus superinfection experiment in cats.

Authors:  M Pistello; D Matteucci; G Cammarota; P Mazzetti; S Giannecchini; D Del Mauro; S Macchi; L Zaccaro; M Bendinelli
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

10.  AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: detailed analysis of the humoral immune response to a protective vaccine.

Authors:  P Mazzetti; S Giannecchini; D Del Mauro; D Matteucci; P Portincasa; A Merico; C Chezzi; M Bendinelli
Journal:  J Virol       Date:  1999-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.